glp-1 receptor agonists effects on cardiovascular risk reduction benefits of glucagon-like peptide-1 GLP-1 Agonists in Cardiovascular Diseases:

Under the circumstances, our MR study, theoretically with minimal reverse causation biases and no heterogeneity and horizontal pleiotropy existing, enjoys an advantage over them

Association of serum carotenoids and tocopherols with atopic diseases in Japanese children and adolescents

Neuroprotective Potential One of the most exciting future applications

How it works: It acts directly on the mitochondria, restoring energy efficiency and reducing cellular inflammation

They also offer opportunities to achieve various public policy objectives, such as mitigating or adapting to climate change, combating land speculation, or promoting a circular economy, through ecofiscal measures or by making property taxes more progressive